Clinical Trial Update: Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a Gonadotropin Releasing Hormone Antagonist for early-onset severe ovarian hyperstimulation syndrome has completed. The study was condu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• GnRH antagonist

Snippet

Sponsor: Ain Shams University | Conditions: Assisted Reproduction | Phase 2 | Status: COMPLETED